ArticleJournal of translational medicine2026
MCM8 promotes colorectal cancer progression by competitively inhibiting HRD1-mediated CDC42 ubiquitination and degradation.
Siyi Qian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.